Meta-analysis of clinical adverse events after CABG vs. PCI in patients with chronic kidney disease and coronary artery disease

Table 1 Study characteristics and sample size, age, sex, follow-up time, outcome indexes, and eGFR evaluation methods (PCI vs. CABG).

Authors	Year	Country	patients(n)			Age (years ± SD)		Male (n, %)		Follow-up (Yrs.)	Outcome indexes	eGFR evaluation
Authors	Year	Country	PCI	GABG	Total	PCI	GABG	PCI	GABG	Follow-up (Yrs.)	Outcome indexes	eGFR evaluation
Lima et al. (18)	2020	Brazil	49	47	96	NR	NR	NR	NR	10	All-cause of death, MI	MDRD equation
Milojevic et al. (8)	2018	Multi-country	158	151	309	72 ± 7	72 ± 8	108 (68)	101 (67)	5	All-cause of death, MACCEs, Cardiac death, MI, Repeated revascularization, Cerebrovascular accident	CKD-EPI equation
Giustino et al. (4)	2018	USA	177	184	361	NR	NR	NR	NR	3	All-cause of death, MACCEs, Cardiac death, MI, Repeated revascularization, Cerebrovascular accident, In-stent thrombosis, Bleeding	CKD-EPI equation
Ix et al. (19)	2005	USA	151	139	290	68 ± 6	69 ± 7	86 (57)	78 (56)	3	All-cause of death, MI, Repeated revascularization, Cerebrovascular accident	Cockcroft-Gault formula
Aoki et al. (20)	2005	Multi-country	69	73	142	70 ± 6	71 ± 6	44 (64)	53 (73)	5	All-cause of death, MACCEs, Cardiac death, MI, Repeated revascularization, Cerebrovascular accident, Pathological Q wave	Cockcroft-Gault formula

MACCEs: Major cardiovascular and cerebrovascular adverse events, MI: myocardial infarction, eGFR: estimated glomerular filtration rate, MDRD: Modification of Diet in Renal Disease, CKD-EPI: CKD Epidemiology Collaboration, NP: not reported

ISSN: 1471-2261